marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-31-2024
Regeneron Pharmaceuticals Financial Ratios 2011-2024 | REGN
Annual Financial Ratios Regeneron Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
25.3 | 19.3 | 8.3 | 14.8 | 17.4 | 18.5 | 33.7 | 40.3 | 68.1 | 120.4 | 67.6 | 22.1 | -36.3 |
P/S |
7.6 | 6.9 | 4.2 | 6.1 | 4.7 | 6.8 | 6.9 | 7.4 | 10.6 | 14.9 | 13.6 | 12.0 | 18.1 |
EPS |
37.0 | 40.5 | 76.4 | 32.6 | 19.4 | 22.6 | 11.3 | 8.6 | 6.2 | 3.4 | 4.2 | 7.9 | -2.5 |
EV (Enterprise Value) |
105 B | 87.1 B | 70.5 B | 55.9 B | 38.8 B | 46.8 B | 42.2 B | 38.1 B | 44.4 B | 42.6 B | 29.2 B | 17.2 B | 8.41 B |
EBITDA per Share |
41.9 | 47.4 | 87.3 | 35.4 | 22.2 | 24.9 | 20.9 | 13.7 | 12.9 | 8.86 | 8.18 | 5.22 | -1.92 |
EV/EBITDA |
7.6 | 13.9 | 14.5 | 16.3 | 17.8 | 24.8 | 32.0 | 46.5 | 35.5 | 33.6 | -45.1 | ||
PEG |
0.92 | 0.57 | 0.15 | 0.58 | -1.2 | 0.18 | 1.06 | 1.04 | 0.87 | -5.99 | -1.49 | 0.05 | 0.38 |
P/B |
3.9 | 3.7 | 3.6 | 4.7 | 3.3 | 5.2 | 6.6 | 8.1 | 11.8 | 16.5 | 14.7 | 13.3 | 16.6 |
P/CF |
21.8 | 16.7 | 9.4 | 19.9 | 18.4 | 25.0 | 39.0 | 37.5 | 66.3 | 102.2 | 67.1 | -133.5 | -40.5 |
ROE % |
15.22 | 19.14 | 43.03 | 31.86 | 19.08 | 27.91 | 19.51 | 20.13 | 17.40 | 13.69 | 21.74 | 60.24 | -45.65 |
ROA % |
11.95 | 14.85 | 31.75 | 20.47 | 14.29 | 20.83 | 13.67 | 12.84 | 11.34 | 8.99 | 14.38 | 36.06 | -16.75 |
ROCE % |
15.58 | 20.91 | 47.67 | 32.44 | 17.39 | 24.63 | 27.26 | 23.22 | 26.09 | 26.06 | 28.66 | 23.88 | -17.46 |
Current Ratio |
4.7 | 4.5 | 3.8 | 2.8 | 3.7 | 4.5 | 3.8 | 2.6 | 3.6 | 3.3 | 6.0 | 7.4 | 4.4 |
DSO |
153.0 | 170.4 | 103.9 | 111.9 | 124.0 | 122.0 | 122.7 | 121.0 | 130.6 | 131.7 | 154.7 | 183.5 | 84.4 |
DIO |
- | - | - | - | 660.5 | 968.0 | 667.5 | 486.4 | 221.7 | 229.4 | 165.3 | 123.8 | 1173.6 |
DPO |
- | - | - | - | 195.1 | 183.5 | 163.8 | 164.4 | 131.0 | 177.2 | 145.5 | 168.3 | 2401.2 |
Operating Cycle |
153.0 | 170.4 | 103.9 | 111.9 | 784.6 | 1090.0 | 790.2 | 607.4 | 352.3 | 361.1 | 319.9 | 307.3 | 1258.0 |
Cash Conversion Cycle |
153.0 | 170.4 | 103.9 | 111.9 | 589.5 | 906.5 | 626.4 | 443.0 | 221.3 | 184.0 | 174.4 | 139.0 | -1143.3 |
All numbers in USD currency
Quarterly Financial Ratios Regeneron Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
12.4 | 13.25 | 6.7 | 9.48 | 9.05 | 7.64 | - | 12.31 | 7.9 | 9.12 | - | 15.37 | 29.51 | 10.58 | 10.9 | 7.98 | 8.19 | 5.69 | 7.25 | 6.12 | 1.77 | 4.23 | 7.58 | 5.5 | 5.12 | 4.44 | 1.62 | 3.64 | 3.66 | 2.36 | 2.41 | 2.53 | 1.88 | 1.74 | 1.49 | 2.04 | 1.89 | 0.74 | 0.89 | 0.89 | 0.89 | 0.89 | 0.98 | 1.44 | 0.89 | 1.02 | 4.92 | 2.02 | 0.81 | 0.12 | -0.58 | -0.68 | -0.69 | -0.49 |
EBITDA per Share |
- | - | 8.03 | - | - | 9.77 | - | 13.7 | 10.3 | 12.5 | - | 19.4 | 31.9 | 11.2 | - | 11.6 | 7.04 | 6.89 | - | 8.18 | 3.83 | 4.88 | - | 6.78 | 6.42 | 5.61 | - | 6.29 | 5.88 | 4.44 | - | 4.18 | 3.25 | 3.38 | - | 4.3 | 3.66 | 2.93 | - | 8.56 | 2.39 | 2.3 | - | 2.72 | 1.81 | 1.68 | - | 2.42 | 1.11 | 0.33 | - | -0.39 | -0.5 | -0.38 |
ROE % |
16.37 | 15.83 | 14.23 | 17.70 | 19.79 | 19.87 | 15.14 | 24.60 | 27.92 | 44.29 | 39.25 | 49.68 | 47.86 | 35.51 | 31.86 | 28.58 | 26.98 | 20.59 | 19.08 | 21.31 | 22.06 | 26.61 | 27.91 | 21.37 | 20.90 | 20.91 | 19.50 | 22.37 | 22.00 | 20.10 | 20.13 | 18.68 | 18.48 | 19.40 | 17.40 | 16.70 | 14.47 | 12.68 | 14.11 | 15.51 | 19.21 | 20.16 | 21.71 | 54.21 | 62.35 | 64.04 | 59.91 | 11.47 | -16.74 | -35.77 | -45.65 | -12.84 | -12.87 | -8.94 |
ROA % |
12.78 | 12.36 | 11.11 | 13.77 | 15.39 | 15.92 | 12.14 | 19.04 | 17.49 | 31.91 | 27.59 | 34.29 | 32.30 | 23.11 | 20.47 | 19.12 | 18.74 | 14.82 | 14.29 | 15.93 | 16.48 | 19.87 | 20.83 | 15.82 | 15.18 | 14.91 | 13.67 | 15.32 | 14.69 | 13.08 | 12.84 | 11.98 | 11.93 | 12.59 | 11.34 | 10.92 | 9.52 | 8.40 | 9.36 | 10.29 | 12.73 | 13.34 | 14.38 | 33.71 | 38.12 | 38.85 | 36.06 | 9.41 | -4.50 | -12.91 | -16.75 | -4.71 | -4.72 | -3.28 |
ROCE % |
15.06 | 15.27 | 15.51 | 18.43 | 19.68 | 20.81 | 17.39 | 28.10 | 33.09 | 49.85 | 42.12 | 51.67 | 50.52 | 34.35 | 21.86 | 28.51 | 25.62 | 22.51 | 13.83 | 20.99 | 21.49 | 25.75 | 20.74 | 29.85 | 31.81 | 33.66 | 25.08 | 33.23 | 32.27 | 29.87 | 22.11 | 32.85 | 35.43 | 38.31 | 27.93 | 36.39 | 57.96 | 56.99 | 57.65 | 61.32 | 41.14 | 40.78 | 28.07 | 44.32 | 48.44 | 47.36 | 25.06 | 13.02 | -15.26 | -34.71 | -32.89 | -12.03 | -12.42 | -8.44 |
Current Ratio |
4.6 | 4.6 | 4.7 | 4.4 | 4.6 | 4.6 | 4.5 | 4.4 | - | 4.1 | 3.8 | 3.7 | 3.4 | 3.1 | 2.8 | 2.8 | 2.8 | 2.8 | 4.0 | 4.0 | 4.0 | 4.0 | 3.9 | 3.9 | 3.9 | 3.9 | 3.3 | 3.3 | 3.3 | 3.3 | 2.8 | 2.8 | 2.8 | 2.8 | 2.9 | 2.9 | 2.9 | 2.9 | 3.0 | 3.0 | 3.0 | 2.9 | 3.0 | 3.0 | 3.0 | 3.0 | 2.5 | 2.5 | 2.5 | 2.5 | 1.6 | 1.6 | 1.6 | 1.6 |
DSO |
145.0 | 140.7 | 156.8 | 145.3 | 147.9 | 150.7 | - | 86.2 | 77.3 | 167.3 | - | 164.5 | 99.2 | 149.5 | 155.0 | 163.7 | 192.3 | 155.1 | 102.8 | 109.9 | 121.5 | 127.1 | 81.6 | 94.5 | 97.8 | 98.5 | 88.7 | 93.6 | 95.5 | 99.7 | 99.9 | 100.5 | 101.1 | 94.8 | 95.8 | 92.5 | 105.3 | 99.3 | 84.1 | 93.0 | 101.3 | 111.3 | 117.7 | 120.3 | 156.9 | 143.2 | 130.6 | 126.6 | 177.8 | 122.3 | 21.0 | 25.1 | 23.9 | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
145.0 | 140.7 | 156.8 | 145.3 | 147.9 | 150.7 | - | 86.2 | 77.3 | 167.3 | - | 164.5 | 99.2 | 149.5 | 155.0 | 163.7 | 192.3 | 155.1 | 102.8 | 109.9 | 121.5 | 127.1 | 81.6 | 94.5 | 97.8 | 98.5 | 88.7 | 93.6 | 95.5 | 99.7 | 99.9 | 100.5 | 101.1 | 94.8 | 95.8 | 92.5 | 105.3 | 99.3 | 84.1 | 93.0 | 101.3 | 111.3 | 117.7 | 120.3 | 156.9 | 143.2 | 130.6 | 126.6 | 177.8 | 122.3 | 21.0 | 25.1 | 23.9 | - |
Cash Conversion Cycle |
145.0 | 140.7 | 156.8 | 145.3 | 147.9 | 150.7 | - | 86.2 | 77.3 | 167.3 | - | 164.5 | 99.2 | 149.5 | 155.0 | 163.7 | 192.3 | 155.1 | 102.8 | 109.9 | 121.5 | 127.1 | 81.6 | 94.5 | 97.8 | 98.5 | 88.7 | 93.6 | 95.5 | 99.7 | 99.9 | 100.5 | 101.1 | 94.8 | 95.8 | 92.5 | 105.3 | 99.3 | 84.1 | 93.0 | 101.3 | 111.3 | 117.7 | 120.3 | 156.9 | 143.2 | 130.6 | 126.6 | 177.8 | 122.3 | 21.0 | 25.1 | 23.9 | - |
All numbers in USD currency